Personalised medicine to relieve the health service
Smaller patient groups and targeted treatments are the future of cancer care in Norway.
top of page
Norwegian Cancer Precision Medicine Implementation Consortium
No upcoming events at the moment
Recordings of past events
Advancing precision cancer medicine via European collaboration
Learn more about the EU-funded Norwegian initiatives PCM4EU and PRIME-ROSE, and the Norwegian MATRIX Centre. Two Norwegian EU-funded...
Success criteria for industry-sponsored clinical trials
The third educational seminar in the clinical trials meeting series arranged by CONNECT Working Group 2 took place via Zoom on 13 February.
CONNECT seminar: investigator-initiated clinical trials
How can researchers have successful collaborations with industry in clinical studies? This was a central question at a recent CONNECT semina
Inclusion of clinical opinions in economic evaluations
How can clinicians be more involved in healthcare decision-making?
Kicking off the Clinical Trials meeting series
Industry-sponsored clinical studies in Norway were in focus at the kick-off meeting for a new meeting series hosted by CONNECT Working Group
The future of precision cancer medicine
The first national initiatives for precision cancer medicine have successfully taken shape in Norway, but what has been achieved and what do
CONNECT seminar on Digital Pathology and AI
Experts from regional, national and international groups shared their perspectives on digital pathology and artificial intelligence (AI)...
CONNECT seminar om Nukleærmedisin
Nukleærmedisin med presisjonsdiagnostikk og persontilpasset behandling. Nukleærmedisin omfatter både diagnostikk og behandling ved bruk...
bottom of page